Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Breast cancer gene tests to be made available to high-risk groups

Breast cancer gene tests to be made available to high-risk groups

9th October 2017

A pioneering new gene test that will show women how high the risk is of them developing breast cancer is to be made available for patients at a hospital in Manchester.

The Single Nucleotide Polymorphism (SNP) test examines DNA samples from blood or saliva to search for 18 genetic variants known to influence breast cancer risks. 

Manchester-based researchers behind the test are now planning to make it available to patients at St Mary's Hospital and Wythenshawe Hospital in Manchester, where it will be used to search for BRCA1 and 2 gene mutations. The tests will be targeted on women with a  family history of the disease.

By establishing risk levels, it could lead to a reduction in the number of women needing to have surgery to remove their breasts. 

Actress Angelina Jolie had pre-emptive breast removal surgery after finding that she had the BRCA genes, giving her an estimated 87 per cent chance of developing breast cancer.

With over 20 years of experience within the consumer market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current consumer roles we have available, you can search for the latest job roles, register your details, or contact the team today.

Image: iStock

We currently have 8 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.